Skip to main content
Caplight Logo









Biolyz

Biolyz

Private
AustriaHealthcare & Life Scienceshttps://www.biolyz.com/

Last Round

Seed

Aug 27, 2024

Total Funding Raised

$1.55M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Biolyz is a biotechnology company that provides a non-invasive, saliva-based biomarker testing platform for monitoring athlete health, performance, and recovery.

Sector

Healthcare & Life Sciences

Verticals

Sports & Fitness, Healthcare Analytics, Medical Devices, Sports Analytics, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

biomarker testingsports analyticsperformance monitoringmass spectrometryathlete recoverynon-invasive diagnosticsinjury preventionsaliva testingphysiological monitoringsports techhealth diagnosticsbiohackingdata-driven trainingbiotechwearable tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biolyz Comparables

Compare Biolyz with similar companies based on industry and business-model similarity.

Biolyz comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Summa Labs
87%
Orreco
80%
Svexa
71%

Biolyz Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 27, 2024
GrantDec 18, 2020

Key People

Founding team and executive leadership

Marlon Millard

CEO

Executive Team

Biolyz Investors

Notable investors and investment history

Biolyz investors
InvestorRounds
accent InkubatorAccelerator
Atrinum Ventures AGSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 3, 2026

    Open roles increased to 9, 3x the trailing average.

  • Jul 25, 2026

    Monthly visitors grew 204% MoM.

Biolyz Filings

Explore SEC and related filing metadata, where available.

Biolyz filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Biolyz's valuation, stock price, and market status.

Is Biolyz a public or private company?

Biolyz is a private company.

What is the current stock price of Biolyz?

Biolyz is a private company with no public stock price. No recent secondary market data is available.

How much is Biolyz worth (valuation)?

Valuation information for Biolyz is not publicly available.

Can I buy Biolyz stock?

Biolyz shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Biolyz's last funding round?

Biolyz's most recent funding round was Seed on August 27, 2024.

Who are the main investors in Biolyz?

Key investors in Biolyz include accent Inkubator.

Will Biolyz IPO soon?

No public IPO plans have been announced for Biolyz.

How can I track Biolyz secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biolyz's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAustria
Employee Range19
Year Founded2020
Last FundingAug 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?